A detailed history of Cerity Partners LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Cerity Partners LLC holds 14,283 shares of ZLAB stock, worth $310,655. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,283
Previous 14,268 0.11%
Holding current value
$310,655
Previous $498,000 2.81%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

BUY
$28.4 - $40.51 $426 - $607
15 Added 0.11%
14,283 $484,000
Q2 2025

Aug 13, 2025

BUY
$24.32 - $43.03 $64,472 - $114,072
2,651 Added 22.82%
14,268 $498,000
Q1 2025

Apr 30, 2025

BUY
$24.29 - $38.35 $282,176 - $445,511
11,617 New
11,617 $419,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.13B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.